A preferable signature of gut microbiota and bile acids predicted better outcomes of unresectable hepatocellular carcinoma to immune checkpoint inhibitors

被引：0
|
作者：
Lee, Pei-Chang [1 ]
Wu, Chijung [1 ]
Hung, Ya-Wen [1 ]
Lee, ChiehJu [1 ]
Chi, Chen-Ta [1 ]
Lee, I-Cheng [1 ]
Luo, Jiing-Chyuan [1 ]
Hou, Ming-Chih [1 ]
Huang, Yi-Hsiang [1 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS160
引用
收藏
页码：S109 / S110
页数：2
相关论文
共 50 条
  • [21] Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
    Han, Feng
    Wang, Xiao-Han
    Xu, Chen-Zhou
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (07)
  • [22] Dual immune checkpoint inhibitors or combined with anti-VEGF agents in advanced, unresectable hepatocellular carcinoma
    Zhang, Bo
    Tao, Baorui
    Li, Yitong
    Yi, Chenhe
    Lin, Zhifei
    Ma, Yue
    Han, Jiahao
    Shao, Weiqing
    Chen, Zhenmei
    Lin, Jing
    Chen, Jinhong
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 111 : 37 - 46
  • [23] IMPACT OF LOW LEVEL VIREMIA ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS THERAPY IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Chen, Jinzhang
    Li, Rong
    Lin, Zhanzhou
    Yang, Qing
    Guan, Yujuan
    Yuan, Guosheng
    Fan, Rong
    Hou, Jinlin
    HEPATOLOGY, 2024, 80
  • [24] Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment
    Liu, Ze-Long
    Liu, Jing-Hua
    Staiculescu, Daniel
    Chen, Jiang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [25] Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
    Li, Xiaomi
    Sun, Wei
    Ding, Xiaoyan
    Li, Wei
    Chen, Jinglong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
    Centrone, Natalia
    Uson Junior, Pedro Luiz Serrano
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (12)
  • [27] Characteristics and prognosis of primary and acquired resistance to immune checkpoint inhibitors combination treatment in unresectable hepatocellular carcinoma
    Chen, X.
    Piao, M.
    Zhou, Z.
    Zhao, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1493 - S1493
  • [28] Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
    Ponziani, Francesca Romana
    De Luca, Angela
    Picca, Anna
    Marzetti, Emanuele
    Petito, Valentina
    Del Chierico, Federica
    Reddel, Sofia
    Paroni Sterbini, Francesco
    Sanguinetti, Maurizio
    Putignani, Lorenza
    Gasbarrini, Antonio
    Pompili, Maurizio
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (06) : 1492 - 1501
  • [29] Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
    Zhu, Chengpei
    Zhang, Chenchen
    Wang, Shanshan
    Xun, Ziyu
    Zhang, Dongya
    Lan, Zhou
    Zhang, Longhao
    Chao, Jiashuo
    Liang, Yajun
    Pu, Zilun
    Ning, Cong
    Sang, Xinting
    Yang, Xiaobo
    Wang, Hanping
    Jiang, Xianzhi
    Zhao, Haitao
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
  • [30] Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
    Wu, Y. Linda
    van Hyfte, Grace
    Ozbek, Umut
    Reincke, Marlene
    Gampa, Anuhya
    Mohamed, Yehia I.
    Nishida, Naoshi
    Wietharn, Brooke
    Amara, Suneetha
    Lee, Pei-Chang
    Scheiner, Bernhard
    Balcar, Lorenz
    Pinter, Matthias
    Vogel, Arndt
    Weinmann, Arndt
    Saeed, Anwaar
    Pillai, Anjana
    Rimassa, Lorenza
    Naqash, Abdul Rafeh
    Muzaffar, Mahvish
    Huang, Yi-Hsiang
    Kaseb, Ahmed O.
    Kudo, Masatoshi
    Pinato, David J.
    Ang, Celina
    FRONTIERS IN ONCOLOGY, 2023, 13
12345